However, an increased amount of intra-tumor levels of IL-22 has been found in CRC and this determines not only an upregulation of anti-apoptotic and pro-proliferating genes [135] but also the induction of abnormal epithelial cell proliferation, as observed in CRC mouse models [136]. This evidence concerns the gene IL22 and colorectal carcinoma.